1. Association between proteomic profile and molecular response in chronic myeloid leukemia patients. Issue 4 (3rd April 2018) Authors: Garrisi, Vito Michele; Sgherza, Nicola; Breccia, Massimo; Iacobazzi, Angela; De Tullio, Giacoma; Nardelli, Giovanni; Negri, Antonio; Divella, Rosa; Daniele, Antonella; Micelli, Giuseppina; Tufaro, Antonio; Cascavilla, Nicola; Savino, Eufemia; Abbate, Ines; Guarini, Attilio Journal: Leukemia & lymphoma Issue: Volume 59:Issue 4(2018) Page Start: 1016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sorafenib: 10 years after the first pivotal trial. (July 2015) Authors: Gadaleta-Caldarola, Gennaro; Infusino, Stefania; Divella, Rosa; Ferraro, Emanuela; Mazzocca, Antonio; De Rose, Ferruccio; Filippelli, Gianfranco; Abbate, Ines; Brandi, Mario Journal: Future oncology Issue: Volume 11:Number 13(2015) Page Start: 1863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond. (August 2015) Authors: Gadaleta-Caldarola, Gennaro; Divella, Rosa; Mazzocca, Antonio; Infusino, Stefania; Ferraro, Emanuela; Filippelli, Gianfranco; Daniele, Antonella; Sabbà, Carlo; Abbate, Ines; Brandi, Mario Journal: Future oncology Issue: Volume 11:Number 16(2015) Page Start: 2263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond. (August 2015) Authors: Gadaleta-Caldarola, Gennaro; Divella, Rosa; Mazzocca, Antonio; Infusino, Stefania; Ferraro, Emanuela; Filippelli, Gianfranco; Daniele, Antonella; Sabbà, Carlo; Abbate, Ines; Brandi, Mario Journal: Future oncology Issue: Volume 11:Number 16(2015) Page Start: 2263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗